Life Sciences in Vienna

554
Organizations
37595
Employees
12.2 bn
Sales / Year
4602
Publications
Source: Vienna Life Science Report 2017/18 (Data: 2017) More Information

News

MedUni Vienna: Cardiovascular diseases: prognostic model from the 1990s still gives the best results

The so-called Framingham cardiovascular risk calculator was developed in 1991 on the basis of data gathered in the USA...

TU Wien: Der virtuelle Graue Star

Das Computergraphik-Team der TU Wien simuliert Augenkrankheiten am Computer. Damit können gesunde Menschen besser...

ÖFG: Katharina Koch-Trappel ist neue Generalsekretärin der Österreichischen Forschungsgemeinschaft

Im Rahmen der Hauptversammlung der Österreichischen Forschungsgemeinschaft (ÖFG) ist Katharina Koch-Trappel am 25....

All news

Twitter @lifesciencevie

Events

21.3. - 23.3.2019

Vienna

SY-Stem 2019

SY-Stem - a symposium focusing on the next generation of stem cell researchers – is an annual meeting, located in the...

Vienna

BBC Europe CEO 2019

Stay at the forefront of European biotech developments in an intimate setting unlike any other.

25.3. - 27.3.2019
International meeting

Vienna

BIO-Europe Spring 2019

BIO-Europe Spring will be held in Vienna, Austria, in 2019 and is hosted by LISAvienna.

All events

Why Vienna?

Philipp von Lattorff - Boehringer Ingelheim
(C) Boehringer Ingelheim / Marion Carniel

Political stability is a major factor when considering major investments in a country. Austria scores very highly in that regard, as it does in terms of infrastructure and standard of living. Without a doubt, however, one of the most important considerations for a research-driven company is research subsidies. This also played a decisive role in the decision to invest 700 million euros in the construction of our new biopharmaceutical production facility in Vienna. We are looking for highly qualified candidates to fill the 500 new positions, created for this project, and attach great importance for that reason to the training and qualifications of potential employees.

Philipp von Lattorff
Managing Director at Boehringer Ingelheim RCV GmbH & Co KG